We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+4.25%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$3.31B
AUM Growth
+$234M
Cap. Flow
+$153M
Cap. Flow %
4.61%
Top 10 Hldgs %
29.6%
Holding
2,810
New
136
Increased
1,119
Reduced
861
Closed
104

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$16.7M
2
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$12.1M
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$10M
4
IWB icon
iShares Russell 1000 ETF
IWB
+$9.45M
5
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$5.09M

Top Sells

Rank Stock Value
1
RDY icon
Dr. Reddy's Laboratories
RDY
+$3.19M
2
HD icon
Home Depot
HD
+$2.88M
3
COOP
Mr. Cooper
COOP
+$2.26M
4
PG icon
Procter & Gamble
PG
+$2.02M
5
CRM icon
Salesforce
CRM
+$1.9M

Sector Composition

Rank Sector Weight
1 Technology 22.8%
2 Financials 12.6%
3 Consumer Discretionary 7.91%
4 Healthcare 7.45%
5 Industrials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VVX icon
2576
V2X
VVX
$2.65B
$1.25K ﹤0.01%
23
– –
NRIX icon
2577
Nurix Therapeutics
NRIX
$2.5B
$1.25K ﹤0.01%
66
– –
WU icon
2578
Western Union
WU
$2.56B
$1.25K ﹤0.01%
134
+71
+113% +$627
COTY icon
2579
Coty
COTY
$2.33B
$1.24K ﹤0.01%
403
-38,245
-99% -$139K
PCT icon
2580
PureCycle Technologies
PCT
$1.21B
$1.18K ﹤0.01%
137
– –
IONQ icon
2581
IonQ
IONQ
$13.6B
$1.17K ﹤0.01%
26
– –
MYGN icon
2582
Myriad Genetics
MYGN
$536M
$1.16K ﹤0.01%
189
– –
KOPN icon
2583
Kopin
KOPN
$700M
$1.16K ﹤0.01%
+494
New +$1.43K
HZO icon
2584
MarineMax
HZO
$806M
$1.14K ﹤0.01%
47
– –
NBBK icon
2585
NB Bancorp
NBBK
$983M
$1.13K ﹤0.01%
57
-297
-84% -$5.65K
ACHR icon
2586
Archer Aviation
ACHR
$3.75B
$1.12K ﹤0.01%
+149
New +$1.4K
CCBG icon
2587
Capital City Bank Group
CCBG
$890M
$1.11K ﹤0.01%
26
-1,206
-98% -$50.3K
SGOV icon
2588
iShares 0-3 Month Treasury Bond ETF
SGOV
$99.3B
$1.1K ﹤0.01%
+11
New +$1.1K
VIR icon
2589
Vir Biotechnology
VIR
$1.52B
$1.1K ﹤0.01%
182
– –
AUR icon
2590
Aurora
AUR
$12.2B
$1.07K ﹤0.01%
+279
New +$1.28K
AOSL icon
2591
Alpha and Omega Semiconductor
AOSL
$935M
$1.07K ﹤0.01%
54
– –
CTEV
2592
Claritev Corp
CTEV
$370M
$1.07K ﹤0.01%
25
– –
BWMN icon
2593
Bowman Consulting
BWMN
$460M
$1.06K ﹤0.01%
32
– –
PVLA
2594
Palvella Therapeutics
PVLA
$2.03B
$1.05K ﹤0.01%
10
– –
ESPR
2595
DELISTED
Esperion Therapeutics
ESPR
$1.04K ﹤0.01%
281
– –
CTRI icon
2596
Centuri Holdings
CTRI
$2.8B
$1.01K ﹤0.01%
40
– –
BNED icon
2597
Barnes & Noble Education
BNED
$425M
$993 ﹤0.01%
108
-172
-61% -$1.52K
CWK icon
2598
Cushman & Wakefield Ltd
CWK
$3.08B
$988 ﹤0.01%
61
– –
CBNK icon
2599
Capital Bancorp
CBNK
$596M
$986 ﹤0.01%
35
-15
-30% -$431
CFFN icon
2600
Capitol Federal Financial
CFFN
$1.08B
$961 ﹤0.01%
141
– –
102 103
104
105 106

Similar funds

BDLIB
Banque de Luxembourg Investments (BLI) Luxembourg City, Luxembourg $3.34B AUM 11.13% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.35B AUM
ECA
Encompass Capital Advisors New York $3.34B AUM 167.64% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
HP
Hancock Prospecting West Perth, Australia $3.33B AUM 65.96% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM

Quadrant Capital Group's Q4 2025 Portfolio in Review

As of Q4 2025, Quadrant Capital Group held 2,810 positions worth $3.31B, up 7.6% from $3.08B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Quadrant Capital Group deployed $153M of net new capital in Q4 2025, opening 136 new positions and adding to 1,119 existing holdings. Its largest new stake was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dr. Reddy's Laboratories, an estimated $3.19M trimmed.

  • Quadrant Capital Group's largest Q4 2025 buy was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.
  • Quadrant Capital Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $16.7M increase.
  • Quadrant Capital Group's biggest Q4 2025 reduction was Dr. Reddy's Laboratories, cutting an estimated $3.19M.
  • Quadrant Capital Group fully exited Mr. Cooper in Q4 2025, selling an estimated $2.26M.
  • Quadrant Capital Group's ten largest holdings make up 30% of its $3.31B portfolio in Q4 2025.
  • Quadrant Capital Group opened 136 new positions and closed 104 in Q4 2025.
  • Quadrant Capital Group's portfolio value rose 7.6% quarter-over-quarter to $3.31B.

Based on Quadrant Capital Group's 13F filing for Q4 2025, filed 13 Feb 2026.